Welcome to Arne Yndestad's research group

Immunological and molecular mechanisms in myocardial remodeling and heart failure

A. Yndestad

Group leader Research Scientist Arne Yndestad, MSc Pharm, PhD

Group members:
PhD Student Christen P. Dahl, MD
PhD-student Linn E. Lillerud, MD
PhD Student Øystein Sandanger, MD
Research Scientist Alexandra V. Finsen, MD, PhD
Research Scientist Leif Erik Vinge, MD, PhD
Research Scientist Erik Øie, MD, PhD
Student Ståle Nymo
Research Scientist Trine Ranheim, MSc, PhD
Engineer Azita Rashidi

Print this page [501 visits]

News & events

Understanding breast cancer
Landscape of cancer genes and mutational processes in breast cancer
May 21, 2012

Untangling the development of breast cancer
Researchers announce the first comprehensive genome studies of the evolution of 21 breast cancers
May 18, 2012

Presentation of prestigious research project
Actionable Targets in Cancer Metastasis (MetAction) – from Bed to Bench to Byte to Bedside
May 16, 2012

GAP cancer conference in Oslo May 14-16
Global Academic Programs 2012
May 11, 2012

Trial lecture and disputation May 9th
Trevor Clancy
May 8, 2012

More news

Latest publications

Arne Yndestad

Bliksøen M, Mariero LH, Ohm IK, Haugen F, Yndestad A, Solheim S, Seljeflot I, Ranheim T, Andersen GO, Aukrust P, Valen G, Vinge LE
Increased circulating mitochondrial DNA after myocardial infarction
Int J Cardiol (in press)
PubMed 22578950

Ueland T, Yndestad A, Dahl CP, Gullestad L, Aukrust P (2012)
TNF Revisited: Osteoprotegerin and TNF-related Molecules in Heart Failure
Curr Heart Fail Rep, 9 (2), 92-100
PubMed 22453763

Yndestad A, Finsen AV, Ueland T, Husberg C, Dahl CP, Øie E, Vinge LE, Sjaastad I, Sandanger Ø, Ranheim T, Dickstein K, Kjekshus J, Damås JK, Fiane AE, Hilfiker-Kleiner D, Lipp M, Gullestad L, Christensen G, Aukrust P (2012)
The homeostatic chemokine CCL21 predicts mortality and may play a pathogenic role in heart failure
PLoS One, 7 (3), e33038
PubMed 22427939